Analytical Methods from Discovery to Diagnostic Development

There are tens of thousands of unmapped molecules circulating in human blood – thousands of which could represent robust biomarkers. Technologies to date have simply been too slow to map them efficiently.

Sapient’s nontargeted metabolomics lab and methods – powered by next-generation rapid liquid chromatography-mass spectrometry (rLC-MS) and a robust follow-on technology pipeline – are changing that, greatly enhancing the breadth and depth with which we can probe both known and unknown small molecule chemistries.